identifi, a product of HaystackAnalytics, is an advanced clinical genomics platform that leverages Next-Generation Sequencing (NGS) technology to deliver comprehensive genetic testing for inherited diseases and personalized medication management. The platform offers diagnostic and pharmacogenomic solutions that support early disease detection, risk assessment, precision treatment, and preventive healthcare. Designed for both healthcare professionals and individuals, identifi makes genomic testing more accessible, applicable, and affordable while advancing personalized medicine.
infexn® is HaystackAnalytics' advanced Next-Generation Sequencing (NGS)-based infectious disease diagnostic platform that rapidly identifies the microorganisms causing an infection directly from clinical samples. It detects a broad range of bacteria, fungi, viruses, and antimicrobial resistance genes, enabling clinicians to diagnose infections accurately and select targeted treatment. By delivering comprehensive, culture-independent results within 12–24 hours, infexn supports faster clinical decision-making, improves patient outcomes, and promotes appropriate antibiotic use.
No reviews yet. Be the first to add a review.